Voluntary prior transparency for the procurement of synthesis modules for PET radiopharmaceutical production
About This Opportunity
TranslatedThis notice concerns the urgent need to replace the existing E&Z synthesis modules within the GMP PET facility, which were installed in 2010. These modules have reached the end of their technical and economic lifespan and require immediate replacement to ensure the reliable continuation of radiopharmaceutical production. The E&Z modules are crucial for producing C-11 and F-18 radiotracers, including compounds such as C-11 PIB, C-11 RACLO, C-11 FLUMA, F-18 MC225, and F18-Olaparib. They are designed to handle complex radiosynthesis processes. Following market consultation, it has been identified that Trasis all-in-one modules are the suitable alternative to the current E&Z modules. These Trasis modules meet current regulations for radiation safety and Good Manufacturing Practice (GMP). The market consultation revealed that Trasis S.A. is the sole supplier capable of providing synthesis modules for PET radiopharmaceutical production that meet the required specifications. Trasis S.A. is uniquely positioned as the only vendor supporting both 18F and 11C radiochemistry production, making their modules essential for maintaining the facility's operational capabilities and compliance with stringent regulatory standards in the field of PET radiopharmaceutical manufacturing.
This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Medical Equipment and Pharmaceuticals. Located in Netherlands, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 530,000.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from DutchThe current E&Z synthesis modules in the GMP PET facility were installed in 2010. The modules have now been technically and economically depreciated and urgently need to be replaced to reliably continue radiopharmaceutical production. The E&Z modules are used for the production of C-11 and F-18 radiotracers such as C-11 PIB, C-11 RACLO, C-11 FLUMA etc. and F-18 MC225, F18- Olaparib etc. The modules are suitable for carrying out more complex radiosyntheses. After market consultation, it has become apparent that the Trasis all-in-one modules are the alternative to the current E&Z modules and comply with current regulations regarding radiation safety and Good Manufacturing Practice. After market consultation, it has become apparent that only Trasis S.A. has the specifications to supply a synthesis module for PET radiopharmaceutical production. Trasis S.A. is the only supplier that supports 18F and 11C radiochemistry production.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on December 15, 2025. Last refreshed 18 days ago. Original language: Dutch. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Universitair Medisch Centrum Groningen (UMCG) / Poliklinische Apotheek UMCG
Universitair Medisch Centrum Groningen (UMCG) / Poliklinische Apotheek UMCG has issued 22 procurement notices on BidsFactory, including 0 currently open and 18 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Research & Innovation. All notices are published for Netherlands. Notices are distributed via TED - Tenders Electronic Daily (EU) and Netherlands TenderNed. Most recent publication: June 10, 2026.
Frequently asked questions about this tender
How much was the contract awarded for?
Trasis SA. was awarded the contract for €500,000. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Netherlands. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Trasis SA.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Universitair Medisch Centrum Groningen (UMCG) / Poliklinische Apotheek UMCG in Netherlands. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.